RBR-94dx93招募中未知
Evaluation of the Sexual Function and Vaginal Microbiota Fractionated Microablative Radiofrequency for the Treatment of Genitourinary Menopause Syndrome
niversidade Federal do Rio Grande do Norte0 个研究点开始时间: 2018年7月2日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 55Y 至 65Y（—）
- 性别
- Female
入选标准
- •The study will include healthy postmenopausal women (55 to 65 years old, with whom at least 12 months have passed since last menstrual period or bilateral oophorectomy), who are still sexually active, with GSM, plasma gonadotropin and presenting serum estradiol levels in the postmenopausal range (FSH >40 U/L; estradiol <25 pg/ml) as well as negative Papanicolaou (Pap) smear for cervical cancer precursor cells.
排除标准
- •Women who have used any form of hormonal (systemic or local) therapy in the last six months, lubricants or vaginal moisturizers in the past month, suffering from active genital infections (diagnosis by GRAM stain and Multiplex-PCR), and any disease that would interfere following the protocol.
研究者
相似试验
尚未招募
不适用
Evaluation of vaginal atrophy symptoms and sexual function in Breast Cancer Survivors after local treatment with RadiofrequencyBreast NeoplasmsSexual Dysfunction, PhysiologicalC12.050.351.500.894.906.316RBR-2ntr3ydniversidade Federal do Rio Grande do Norte
已完成
4 期
FDC116115: A prospective study of sexual function in sexually active men treated for BPHbenign prostate hyperplasiaprostate enlargement10036958NL-OMON44013GlaxoSmithKline BV83
进行中（未招募）
1 期
A study of sexual function in sexually active men treated for BPHEUCTR2012-002047-26-ESGlaxoSmithKline, S.A.476
进行中（未招募）
1 期
A study of sexual function in sexually active men treated for BPHEUCTR2012-002047-26-GRGlaxoSmithKline Research & Development Limited476
进行中（未招募）
不适用
A study of sexual function in sexually active men treated for BPHBPH (Benign prostatic hyperplasiaMedDRA version: 17.0Level: PTClassification code 10004446Term: Benign prostatic hyperplasiaSystem Organ Class: 10038604 - Reproductive system and breast disordersEUCTR2012-002047-26-DEGlaxoSmithKline Research & Development Limited476